Novartis seeks to deepen India innovation play
NEW DELHI: Swiss pharma major Novartis is sharpening its strategy in India as a pure-play innovator across core therapy segments, including cardiovascular, oncology and immunology, after divesting its stake in its listed arm earlier this year.Significantly, India increasingly contributes to nearly every molecule that Novartis commercialises globally, and is moving further up the value chain,…